Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Both genetic and lifestyle factors significantly affect female hair loss.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.